CMPS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Compass Pathways Plc

NASDAQ | CMPS

5.49

USD

$0.00

(

0.00%

)

At Close (As of Nov 5, 2025)

$636.59M

Market Cap

-

P/E Ratio

-2.72

EPS

$7.08

52 Week High

$2.25

52 Week Low

HEALTHCARE

Sector

CMPS Chart

Recent Chart
Price Action

CMPS Technicals

Tags:

CMPS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$178M
Selling General And Administrative $59M
Research And Development $119M
Operating Expenses $178M
Investment Income Net -
Net Interest Income $3.8M
Interest Income $8.3M
Interest Expense $4.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $233K
Income Before Tax -$154M
Income Tax Expense -$1.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$155M
Comprehensive Income Net Of Tax -
Ebit -$178M
Ebitda -$178M
Net Income -$155M

Revenue & Profitability

Earnings Performance

CMPS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $214M
Total Current Assets $201M
Cash And Cash Equivalents At Carrying Value $165M
Cash And Short Term Investments $165M
Inventory -
Current Net Receivables $22M
Total Non Current Assets $12M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $469K
Short Term Investments -
Other Current Assets $14M
Other Non Current Assets -
Total Liabilities $59M
Total Current Liabilities $34M
Current Accounts Payable $12M
Deferred Revenue -
Current Debt -
Short Term Debt $7.2M
Total Non Current Liabilities $25M
Capital Lease Obligations $2M
Long Term Debt $25M
Current Long Term Debt $5.5M
Long Term Debt Noncurrent -
Short Long Term Debt Total $32M
Other Current Liabilities $14M
Other Non Current Liabilities -
Total Shareholder Equity $155M
Treasury Stock -
Retained Earnings -$535M
Common Stock $702K
Common Stock Shares Outstanding $67M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$119M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $233K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $64M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$155M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$178M
Selling General And Administrative $59M
Research And Development $119M
Operating Expenses $178M
Investment Income Net -
Net Interest Income $3.8M
Interest Income $8.3M
Interest Expense $4.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $233K
Income Before Tax -$154M
Income Tax Expense -$1.6M
Interest And Debt Expense -
Net Income From Continuing Operations -$155M
Comprehensive Income Net Of Tax -
Ebit -$178M
Ebitda -$178M
Net Income -$155M

CMPS News

CMPS Profile

Compass Pathways Plc Profile

Sector: HEALTHCARE

Industry: MEDICAL CARE FACILITIES

Compass Pathways plc is a leading mental health care company dedicated to innovating treatments for mental health conditions through the development of psychedelic therapies, particularly psilocybin. Based in Cheshire, UK, and active in both the UK and US markets, the company is at the forefront of clinical research aimed at addressing significant unmet needs in mental health care, notably for treatment-resistant depression. With a robust commitment to research and development, Compass Pathways is poised to redefine the standards of mental health treatment, contributing to the advancement of therapeutic options that promise to enhance patient outcomes on a global scale.

CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.18%
$2.68
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
CPNG
-5.94%
$30.22
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.18%
$2.68
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
CPNG
-5.94%
$30.22
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.